What Changed
- The Department of Health lifted its directive prohibiting Heal Fertility Limited from accepting new patients for assisted reproductive technology procedures starting October 6, 2026.
- The Council on Human Reproductive Technology confirmed proper execution of remedial measures and approved the full resumption of all 17 licensed treatment services.
- The regulator investigated and addressed the facility's failure to report a Serious Untoward Event within the statutory 24-hour timeframe required under Cap. 633.
The Department of Health (DH) of the Hong Kong Special Administrative Region (Hong Kong SAR) announced on October 5, 2026, that it has lifted an administrative directive suspending "Heal Fertility Limited" from accepting new patients for assisted reproductive technology procedures. The private centre is permitted to fully resume accepting new patients and provide all 17 treatment services covered by its licence starting October 6, 2026.
The suspension directive was originally imposed after a Serious Untoward Event occurred at the facility involving a mix-up in embryo biopsy specimens. Additionally, the centre failed to report the Serious Untoward Event to the DH within 24 hours of identification, as mandated by the Code of Practice for Day Procedure Centres (Code of Practice) under the Private Healthcare Facilities Ordinance (Cap. 633).
Following an investigation completed early last month, the DH confirmed that the centre implemented a comprehensive series of improvement and remedial measures to correct operational deficiencies, prevent the recurrence of similar incidents, and ensure future compliance with mandatory reporting obligations. The Council on Human Reproductive Technology (Council) subsequently verified that all required remedial measures had been properly executed and approved the full resumption of services.
In light of the Council's confirmation, the DH formally lifted its suspension directive. The DH reminded all licensed private healthcare facilities providing reproductive technology procedures that they must strictly comply with all statutory standards, licensing conditions, and Codes of Practice. The regulator emphasized that non-compliance will trigger regulatory enforcement based on the risk posed to patient safety.
Who May Be Affected
Private healthcare facilities, assisted reproductive technology operators, and patients seeking fertility treatments in Hong Kong SAR.
Cross-Border Context
Relevant to international patients, investors, and medical services firms operating or accessing assisted reproductive technology procedures in Hong Kong SAR under local licensing regulations.
What to check next
- Code of Practice for Day Procedure Centres under the Private Healthcare Facilities Ordinance (Cap. 633).
- Licensing conditions and regulatory updates issued by the Council on Human Reproductive Technology.
This article provides general information and does not constitute legal advice. Consult the official text and obtain advice appropriate to your circumstances where needed.